Incidence of childhood renal tumours: An international population‐based study

Malignant renal tumours represent 5% of childhood cancers and include types with likely different aetiology: Wilms tumour (WT), rhabdoid renal tumour, kidney sarcomas and renal carcinomas. WT is the most common renal tumour in children, previously shown to vary internationally and with ethnicity. Us...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer Vol. 147; no. 12; pp. 3313 - 3327
Main Authors: Nakata, Kayo, Colombet, Murielle, Stiller, Charles A., Pritchard‐Jones, Kathy, Steliarova‐Foucher, Eva
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 15-12-2020
Wiley Subscription Services, Inc
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Malignant renal tumours represent 5% of childhood cancers and include types with likely different aetiology: Wilms tumour (WT), rhabdoid renal tumour, kidney sarcomas and renal carcinomas. WT is the most common renal tumour in children, previously shown to vary internationally and with ethnicity. Using the comprehensive database of the International Incidence of Childhood Cancer study (IICC), we analysed global variations and time trends in incidence of renal tumour types in children (age 0‐14 years) and adolescents (age 15‐19 years). The results were presented by 14 world regions, and five ethnic groups in the US. We included 15 320 renal tumours in children and 800 in adolescents reported to the 163 contributing registries during 2001‐2010. In children, age‐standardised incidence rate (ASR) of renal tumours was 8.3 per million (95% confidence interval, CI = 8.1, 8.4); it was the highest in North America and Europe (9‐10 per million) and the lowest in most Asian regions (4‐5 per million). In the US, Blacks had the highest ASR (10.9 per million, 95% CI = 10.2, 11.6) and Asian and Pacific Islanders the lowest (4.4 per million, 95% CI = 3.6, 5.1). In adolescents, age‐specific incidence rate of renal tumours was 1.4 per million (95% CI = 1.3, 1.5). WT accounted for over 90% of all renal tumours in each age from 1 to 7 years and the proportion of renal carcinomas increased gradually with age. From 1996 to 2010, incidence remained mostly stable for WT (average annual percent change, AAPC = 0.1) and increased for renal carcinomas in children (AAPC = 3.7) and adolescents (AAPC = 3.2). Our findings warrant further monitoring. What's new? Based on more than 16,000 incident cases in the period 2001‐2010, this study offers the most complete overview to date of the worldwide patterns of renal tumours in children and adolescents. Using the comprehensive International Incidence of Childhood Cancer database, the authors also describe the distribution of rare entities such as rhabdoid renal tumour or kidney sarcomas. The results indicate the stable incidence of Wilms tumour, the most common renal tumour in children, consistently with a likely genetic origin. The rising incidence of renal carcinomas with age and over time is likely caused by environmental risk factors, warranting further monitoring.
Bibliography:Funding information
Union for International Cancer Control TechnicalFellowship, Grant/Award Number: UICC‐TF/18/534491; Ministry of Health, Labour and Welfare, Japan, Grant/Award Number: 20EA1026
Selected preliminary results were displayed in a poster of the 51st congress of the International Society of Paediatric Oncology and the abstract of this communication was published in Paediatric Blood and Cancer, Volume 66, Issue S4
https://doi.org/10.1002/pbc.27989
IICC‐3 Contributors listed in Appendix.
Correction added on 3 September 2020, after first online publication: There is a change in copright and ‘United States’ has been changed to ‘US’ throughout the article.
Disclaimer
Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organisation, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organisation.
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Funding information Union for International Cancer Control TechnicalFellowship, Grant/Award Number: UICC‐TF/18/534491; Ministry of Health, Labour and Welfare, Japan, Grant/Award Number: 20EA1026
Disclaimer: Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organisation, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organisation.
Selected preliminary results were displayed in a poster of the 51st congress of the International Society of Paediatric Oncology and the abstract of this communication was published in Paediatric Blood and Cancer, Volume 66, Issue S4 (https://doi.org/10.1002/pbc.27989).
ISSN:0020-7136
1097-0215
DOI:10.1002/ijc.33147